GlaxoSmithKline | GSK - Ingresos Por Ventas

Precio De Mercado
1,902.00
Cambio Diario
25.50 1.36%
Mensual
-11.29%
Anual
34.37%
Q2 Expectativa
1,829.35




Ventas Cambio Fecha
AbbVie USD 15B 1.62B 2026-03
Alcon AG USD 2.69B 10M 2026-03
Almirall EUR 547.63M 12.83M 2025-12
Amgen USD 8.62B 1.28B 2026-03
argenx SE USD 1.12B 0 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Fresenius EUR 5.74B 140M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
GRIFOLS EUR 1.7B 280M 2026-03
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Novo Nordisk DKK 96.82B 17.68B 2026-03
Orion EUR 417.7M 277.6M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Philips EUR 3.91B 1.19B 2026-03
Recordati EUR 713.42M 51.42M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
UCB EUR 4.25B 764M 2025-12